Celexa Strategies: Negotiation, Mediation, Arbitration, and Litigation

September 26, 2012

Based on several medical studies, Celexa (citalopram) may have caused thousands of families pain, frustration, and expense. Research suggests that women pregnant women ingest Celexa, the fetus developing inside them may receive harmful levels of exposure. Moreover, late pregnancy exposure may dramatically increase the risk of respiratory complications.

 

To make matters worse, these product defects may have been the result of insufficient research prior to putting this powerful antidepressant into the stream of commerce. On this basis, Celexa victims are seeking compensation. Some victims are willing to pursue a variety of legal avenues, including negotiation, mediation, arbitration, and litigation.

 

Want to find out how these legal avenues might suit your needs and desires? The professionals at the law firm of Fears Nachawati can help you answer your questions. With years of experience and dedicated expertise, we know how to represent your needs. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

More Blog Posts

CONTACT US

Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears | Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law

Locations

With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears | Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consulation

Live Chat (Online Now)